Forvia (FRVIA) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 2024 sales reached €6.36bn, outperforming global automotive production by 420bps despite a 4.6% YoY industry decline, driven by strong results in Europe and North America, and robust growth in Seating and Interiors.
Challenging environment in H2 2024 with a pause in electrification and significant production declines, especially in Europe and North America.
Cumulative order intake surpassed €20bn YTD, with a target of €30bn for the year, driven by selective, profitable contracts, especially in Asia and Electronics, and major wins with Chinese OEMs.
Major new awards include contracts with Xiaomi (EV market entry), Volvo Interiors (€300m), and renewed activity in Clean Mobility.
Financial highlights
Q3 2024 revenues reached €6.357bn, down 2.6% YoY, with organic growth at -0.4% and negative currency/scope effects; outperformed the market by 420bps.
Organic growth in Europe (+4.1%) and Americas (+2.4%), but a 9.9% decline in Asia, mainly due to China.
Seating grew organically by 4.9%, Interiors by 5.9%, while Clean Mobility declined by 10.1% due to Stellantis and China activity drops.
Electronics showed outperformance in North America and Europe, but a negative mix in China; Lighting grew 6% (including JV consolidation), but organic growth was -1.4% due to production delays.
Outlook and guidance
FY 2024 guidance confirmed: revenues €26.8–27.2bn, operating margin 5.0–5.3%, net cash flow at least €550m, leverage at or below 2.0x by year-end.
2025 expectations: flat global markets, slight growth in China, slight decline in Europe, with CAFE regulation as a key uncertainty.
Outperformance of 300–500bps expected to continue, with cost reductions of ~€300m in 2025 P&L (1% of sales) from synergies and EU-FORWARD plan.
Targeting net debt/Adjusted EBITDA <1.5x by end-2025, supported by asset disposals and improved cash flow.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - Operating margin and cash flow rose, guidance confirmed despite SYMBIO-related net loss.FRVIA
Q2 20253 Feb 2026 - 2.7% organic sales growth, margin gains, and deleveraging progress marked H1 2024.FRVIA
Q2 20243 Feb 2026 - Q1 2025 sales up 2.6% to €6.7bn, 2025 guidance confirmed amid market volatility.FRVIA
Q1 202525 Dec 2025 - Resilient 2024 results, strong cash flow, and further deleveraging targeted for 2025.FRVIA
Q4 202418 Dec 2025 - Resilient results, new CEO, and strategic focus on sustainability and deleveraging highlighted.FRVIA
AGM 202520 Nov 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025